Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer

OBJECTIVES: Nivolumab, a fully IgG4-programmed death-1 inhibitor antibody, led to improved overall survival compared with single-agent therapy in patients with platinum-refractory recurrent head and neck cancers. In general, nivolumab is used in inoperable patients. To the best of our knowledge, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsushima, Nayuta, Shinozaki, Takeshi, Fujisawa, Takao, Tomioka, Toshifumi, Okano, Wataru, Ikeda, Masakazu, Tahara, Makoto, Higashino, Takuya, Hayashi, Ryuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169354/
https://www.ncbi.nlm.nih.gov/pubmed/32341668
http://dx.doi.org/10.1177/1179547620908854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169354/
https://www.ncbi.nlm.nih.gov/pubmed/32341668
http://dx.doi.org/10.1177/1179547620908854

Ejemplares similares